collage of photos illustrating the breadth of UMB research including children with toothbrushes, a map of Malawi, and bench science photos.

The Office of Research and Development (ORD) is the chief administrative unit and catalyst for advancing research and economic development at UMB.

University of Maryland, Baltimore (UMB) is a leading academic medical research institution. In Fiscal Year 2019, the University was awarded more than $665 million in sponsored biomedical research, and each year UMB receives more than $60 million in awards from more than 300 bioscience and pharmaceutical corporate partners.

ORD provides high-quality services to investigators, fostering new research and clinical initiatives with industry, and commercializing breakthrough therapies, diagnostics, and devices. Using targeted investments, ORD fuels the creation of innovative start-up companies and attracts industry leaders and entrepreneurs to UMB’s thriving downtown campus.

Services to support UMB’s researchers and advance research and economic development include:

  • Intellectual property protection
  • Technology licensing to push UMB’s most promising discoveries to market
  • Business development and entrepreneurial support programs to help investigators fund their research
  • Targeted economic development initiatives to encourage the location of University-created or -sponsored companies in Baltimore
  • Industry partnership
  • Early-stage startup investment funding

The UM BioPark
The UM BioPark, UMB’s 14-acre research park managed by ORD, draws industry-leading biotech and life science firms from around the world. Located adjacent to UMB’s campus, BioPark tenant companies are able to easily collaborate with UMB’s renowned researchers, centers of excellence, and institutes. Learn more about the BioPark at umbiopark.com.